Impact of immunosuppressive agents on the management of immune-related adverse events of immune checkpoint blockers

Immune checkpoint blockers (ICBs) can induce immune-related adverse events (irAEs) whose management is based on expert opinion and may require the prescription of steroids and/or immunosuppressants (ISs). Recent data suggest that these treatments can reduce the effectiveness of ICBs.

Source: European Journal of Cancer - April 13, 2024 Category: Cancer & Oncology Authors: Pierre-Louis Cariou, C édric Pobel, Jean-Marie Michot, François-Xavier Danlos, Benjamin Besse, Franck Carbonnel, Xavier Mariette, Aurélien Marabelle, Sabine Messayke, Caroline Robert, Emilie Routier, Nicolas Noël, Olivier Lambotte Tags: Original Research Source Type: research